デオキシヌクレオチド三リン酸塩(dNTP)の世界市場2024~2028

■ 英語タイトル:Global Deoxynucleotide Triphosphates (dNTPs) Market 2024-2028

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR76776-24)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR76776-24
■ 発行日:2023年11月9日
■ 調査対象地域:グローバル
■ 産業分野:化学
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[デオキシヌクレオチド三リン酸塩(dNTP)の世界市場2024~2028]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

デオキシヌクレオチド三リン酸塩(dNTP)の世界市場 2024-2028
デオキシヌクレオチド三リン酸塩(dNTP)市場は2023-2028年に77.45百万米ドルの成長が予測され、予測期間中のCAGRは7.26%で加速すると予測されています。この調査レポートは、デオキシヌクレオチド三リン酸塩(dNTP)市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25の企業を網羅した企業分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、バイオメディカル分野でのPCRの台頭、DNAシーケンシングの用途拡大、DNA合成手順の増加によって牽引されています。

Technavioのデオキシヌクレオチド三リン酸塩(dNTP)市場は以下のように区分されます:

製品タイプ別
- 液体DNTPS
- 固体DNTPS

用途別
- 研究機関
- 医薬品

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本研究では、今後数年間のデオキシヌクレオチド三リン酸塩(dNTP)市場の成長を促進する主な理由の一つとして、RT-PCRのアプリケーションの増加を挙げています。また、シーケンシング技術の進歩や、治療・診断ツールとしてのオリゴヌクレオチドの使用の増加は、市場の大きな需要につながるでしょう。

この調査レポートは、デオキシヌクレオチド三リン酸塩(dNTP)市場を調査・分析し、以下の市場分野を対象としています:
- デオキシヌクレオチド三リン酸塩(dNTP)市場の規模
- デオキシヌクレオチド三リン酸塩(dNTP)市場予測
- デオキシヌクレオチド三リン酸塩(dNTP)市場産業分析

本レポートでは、デオキシヌクレオチド三リン酸塩(dNTP)市場の主要企業として、biotechrabbit GmbH、BR Biochem Life Sciences Pvt. Ltd.、Creative Biogene、Geneaid Biotech Ltd.、Hefei Huana Biomedical Technology Co. Ltd.、Hzymes Biotechnology Co. Ltd.、Jena Bioscience GmbH、Larova GmbH、Maravai LifeSciences Holdings Inc.、MCLAB、Merck KGaA、Meridian Bioscience Inc.、Promega Corp.、SBS Genetech Co. Ltd.、Thermo Fisher Scientific Inc.、Wizbiosolutions Inc.、WUHU HUAREN SCIENCE AND TECHNOLOGY CO. LTD.、New England Biolabs Inc.、Takara Bio Inc.などが含まれています。また、デオキシヌクレオチド三リン酸塩(dNTP)市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要企業の分析に加え、包括的な市場および企業ランドスケープが含まれています。
当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密な企業選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 デオキシヌクレオチド三リン酸塩(dNTP)の世界市場規模:製品タイプ別
7 デオキシヌクレオチド三リン酸塩(dNTP)の世界市場規模:用途別
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global deoxynucleotide triphosphates (dNTPs) market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global deoxynucleotide triphosphates (dntps) market 2018 – 2022 ($ million)
o 4.2 Product Type Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Product Type Segment 2018 – 2022 ($ million)
o 4.3 Application Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Application Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Product Type
o 6.1 Market segments
o Exhibit 30: Chart on Product Type – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product Type – Market share 2023-2028 (%)
o 6.2 Comparison by Product Type
o Exhibit 32: Chart on Comparison by Product Type
o Exhibit 33: Data Table on Comparison by Product Type
o 6.3 Liquid dNTPs – Market size and forecast 2023-2028
o Exhibit 34: Chart on Liquid dNTPs – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Liquid dNTPs – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Liquid dNTPs – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Liquid dNTPs – Year-over-year growth 2023-2028 (%)
o 6.4 Solid dNTPs – Market size and forecast 2023-2028
o Exhibit 38: Chart on Solid dNTPs – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Solid dNTPs – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Solid dNTPs – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Solid dNTPs – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Product Type
o Exhibit 42: Market opportunity by Product Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Product Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Application – Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Research institutions – Market size and forecast 2023-2028
o Exhibit 48: Chart on Research institutions – Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Research institutions – Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Research institutions – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Research institutions – Year-over-year growth 2023-2028 (%)
o 7.4 Pharmaceutical – Market size and forecast 2023-2028
o Exhibit 52: Chart on Pharmaceutical – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Pharmaceutical – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Pharmaceutical – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Pharmaceutical – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Application
o Exhibit 56: Market opportunity by Application ($ million)
o Exhibit 57: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 63: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 79: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 UK – Market size and forecast 2023-2028
o Exhibit 83: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 China – Market size and forecast 2023-2028
o Exhibit 91: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 95: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 biotechrabbit GmbH
o Exhibit 107: biotechrabbit GmbH – Overview
o Exhibit 108: biotechrabbit GmbH – Product / Service
o Exhibit 109: biotechrabbit GmbH – Key offerings
o 12.4 Central Glass Co. Ltd.
o Exhibit 110: Central Glass Co. Ltd. – Overview
o Exhibit 111: Central Glass Co. Ltd. – Business segments
o Exhibit 112: Central Glass Co. Ltd. – Key offerings
o Exhibit 113: Central Glass Co. Ltd. – Segment focus
o 12.5 Creative Biogene
o Exhibit 114: Creative Biogene – Overview
o Exhibit 115: Creative Biogene – Product / Service
o Exhibit 116: Creative Biogene – Key offerings
o 12.6 Geneaid Biotech Ltd.
o Exhibit 117: Geneaid Biotech Ltd. – Overview
o Exhibit 118: Geneaid Biotech Ltd. – Product / Service
o Exhibit 119: Geneaid Biotech Ltd. – Key offerings
o 12.7 Jena Bioscience GmbH
o Exhibit 120: Jena Bioscience GmbH – Overview
o Exhibit 121: Jena Bioscience GmbH – Product / Service
o Exhibit 122: Jena Bioscience GmbH – Key offerings
o 12.8 Maravai LifeSciences Holdings Inc.
o Exhibit 123: Maravai LifeSciences Holdings Inc. – Overview
o Exhibit 124: Maravai LifeSciences Holdings Inc. – Business segments
o Exhibit 125: Maravai LifeSciences Holdings Inc. – Key offerings
o Exhibit 126: Maravai LifeSciences Holdings Inc. – Segment focus
o 12.9 MCLAB
o Exhibit 127: MCLAB – Overview
o Exhibit 128: MCLAB – Product / Service
o Exhibit 129: MCLAB – Key offerings
o 12.10 Merck KGaA
o Exhibit 130: Merck KGaA – Overview
o Exhibit 131: Merck KGaA – Business segments
o Exhibit 132: Merck KGaA – Key news
o Exhibit 133: Merck KGaA – Key offerings
o Exhibit 134: Merck KGaA – Segment focus
o 12.11 Meridian Bioscience Inc.
o Exhibit 135: Meridian Bioscience Inc. – Overview
o Exhibit 136: Meridian Bioscience Inc. – Business segments
o Exhibit 137: Meridian Bioscience Inc. – Key offerings
o Exhibit 138: Meridian Bioscience Inc. – Segment focus
o 12.12 New England Biolabs Inc.
o Exhibit 139: New England Biolabs Inc. – Overview
o Exhibit 140: New England Biolabs Inc. – Product / Service
o Exhibit 141: New England Biolabs Inc. – Key news
o Exhibit 142: New England Biolabs Inc. – Key offerings
o 12.13 Promega Corp.
o Exhibit 143: Promega Corp. – Overview
o Exhibit 144: Promega Corp. – Product / Service
o Exhibit 145: Promega Corp. – Key offerings
o 12.14 SBS Genetech Co. Ltd.
o Exhibit 146: SBS Genetech Co. Ltd. – Overview
o Exhibit 147: SBS Genetech Co. Ltd. – Product / Service
o Exhibit 148: SBS Genetech Co. Ltd. – Key offerings
o 12.15 Takara Bio Inc.
o Exhibit 149: Takara Bio Inc. – Overview
o Exhibit 150: Takara Bio Inc. – Business segments
o Exhibit 151: Takara Bio Inc. – Key offerings
o Exhibit 152: Takara Bio Inc. – Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 153: Thermo Fisher Scientific Inc. – Overview
o Exhibit 154: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 155: Thermo Fisher Scientific Inc. – Key news
o Exhibit 156: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 157: Thermo Fisher Scientific Inc. – Segment focus
o 12.17 Wizbiosolutions Inc.
o Exhibit 158: Wizbiosolutions Inc. – Overview
o Exhibit 159: Wizbiosolutions Inc. – Product / Service
o Exhibit 160: Wizbiosolutions Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 161: Inclusions checklist
o Exhibit 162: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 163: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 164: Research methodology
o Exhibit 165: Validation techniques employed for market sizing
o Exhibit 166: Information sources
o 13.5 List of abbreviations
o Exhibit 167: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global deoxynucleotide triphosphates (dntps) market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Product Type Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Application Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Product Type – Market share 2023-2028 (%)
Exhibits31: Data Table on Product Type – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product Type
Exhibits33: Data Table on Comparison by Product Type
Exhibits34: Chart on Liquid dNTPs – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Liquid dNTPs – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Liquid dNTPs – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Liquid dNTPs – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Solid dNTPs – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Solid dNTPs – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Solid dNTPs – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Solid dNTPs – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product Type ($ million)
Exhibits43: Data Table on Market opportunity by Product Type ($ million)
Exhibits44: Chart on Application – Market share 2023-2028 (%)
Exhibits45: Data Table on Application – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Research institutions – Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Research institutions – Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Research institutions – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Research institutions – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Pharmaceutical – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Pharmaceutical – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Pharmaceutical – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Pharmaceutical – Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Application ($ million)
Exhibits57: Data Table on Market opportunity by Application ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: biotechrabbit GmbH – Overview
Exhibits108: biotechrabbit GmbH – Product / Service
Exhibits109: biotechrabbit GmbH – Key offerings
Exhibits110: Central Glass Co. Ltd. – Overview
Exhibits111: Central Glass Co. Ltd. – Business segments
Exhibits112: Central Glass Co. Ltd. – Key offerings
Exhibits113: Central Glass Co. Ltd. – Segment focus
Exhibits114: Creative Biogene – Overview
Exhibits115: Creative Biogene – Product / Service
Exhibits116: Creative Biogene – Key offerings
Exhibits117: Geneaid Biotech Ltd. – Overview
Exhibits118: Geneaid Biotech Ltd. – Product / Service
Exhibits119: Geneaid Biotech Ltd. – Key offerings
Exhibits120: Jena Bioscience GmbH – Overview
Exhibits121: Jena Bioscience GmbH – Product / Service
Exhibits122: Jena Bioscience GmbH – Key offerings
Exhibits123: Maravai LifeSciences Holdings Inc. – Overview
Exhibits124: Maravai LifeSciences Holdings Inc. – Business segments
Exhibits125: Maravai LifeSciences Holdings Inc. – Key offerings
Exhibits126: Maravai LifeSciences Holdings Inc. – Segment focus
Exhibits127: MCLAB – Overview
Exhibits128: MCLAB – Product / Service
Exhibits129: MCLAB – Key offerings
Exhibits130: Merck KGaA – Overview
Exhibits131: Merck KGaA – Business segments
Exhibits132: Merck KGaA – Key news
Exhibits133: Merck KGaA – Key offerings
Exhibits134: Merck KGaA – Segment focus
Exhibits135: Meridian Bioscience Inc. – Overview
Exhibits136: Meridian Bioscience Inc. – Business segments
Exhibits137: Meridian Bioscience Inc. – Key offerings
Exhibits138: Meridian Bioscience Inc. – Segment focus
Exhibits139: New England Biolabs Inc. – Overview
Exhibits140: New England Biolabs Inc. – Product / Service
Exhibits141: New England Biolabs Inc. – Key news
Exhibits142: New England Biolabs Inc. – Key offerings
Exhibits143: Promega Corp. – Overview
Exhibits144: Promega Corp. – Product / Service
Exhibits145: Promega Corp. – Key offerings
Exhibits146: SBS Genetech Co. Ltd. – Overview
Exhibits147: SBS Genetech Co. Ltd. – Product / Service
Exhibits148: SBS Genetech Co. Ltd. – Key offerings
Exhibits149: Takara Bio Inc. – Overview
Exhibits150: Takara Bio Inc. – Business segments
Exhibits151: Takara Bio Inc. – Key offerings
Exhibits152: Takara Bio Inc. – Segment focus
Exhibits153: Thermo Fisher Scientific Inc. – Overview
Exhibits154: Thermo Fisher Scientific Inc. – Business segments
Exhibits155: Thermo Fisher Scientific Inc. – Key news
Exhibits156: Thermo Fisher Scientific Inc. – Key offerings
Exhibits157: Thermo Fisher Scientific Inc. – Segment focus
Exhibits158: Wizbiosolutions Inc. – Overview
Exhibits159: Wizbiosolutions Inc. – Product / Service
Exhibits160: Wizbiosolutions Inc. – Key offerings
Exhibits161: Inclusions checklist
Exhibits162: Exclusions checklist
Exhibits163: Currency conversion rates for US$
Exhibits164: Research methodology
Exhibits165: Validation techniques employed for market sizing
Exhibits166: Information sources
Exhibits167: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR76776-24 )"デオキシヌクレオチド三リン酸塩(dNTP)の世界市場2024~2028" (英文:Global Deoxynucleotide Triphosphates (dNTPs) Market 2024-2028)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。